Monday, February 25th, 2008...3:36 pm
CRME +30% as FDA is about to make decision
Jump to Comments
CRME - Cardiome Pharma (CRME message board) is up 30% as investors await the FDA decision on their Kynapid drug which restores normal heart rhythem in patients with arterial fibrillation.
Leave a Reply
You must be logged in to post a comment.